Results 161 to 170 of about 762,836 (292)

Whole Genome Characterization of Klebsiella Strains in European Hedgehogs and Human Nosocomial Settings Identified Shared Sequence Types, Antimicrobial Resistance Genes and Plasmids

open access: yesZoonoses and Public Health, EarlyView.
ABSTRACT Introduction Klebsiella pneumoniae is a pathogen associated with healthcare‐acquired infections and antimicrobial resistance (AMR) to beta‐lactams and carbapenems. Although wild animals are not typically exposed to antibiotics, they can harbour resistant strains. The European hedgehog (Erinaceus europaeus) is increasingly found in urban areas,
Biel Garcias   +5 more
wiley   +1 more source

Gel electrofocusing combined with zymogram techniques for the characterization of β-lactamases from gram negative bacteria [PDF]

open access: yesFEMS Microbiology Letters, 1977
B. Olsson   +3 more
openaire   +1 more source

Additional file 1: of Efficacy of Andrographis paniculata against extended spectrum β-lactamase (ESBL) producing E. coli

open access: yes, 2018
FTIR analysis, antibiotic susceptibility testing and phenotypic detection of ESBL production. The data in the file includes the FTIR spectra of CEA extract, antibiotic susceptibility data of three clinical strains of E. coli and double disk diffusion test for ESBL production. (PDF 180 kb)
Rasool, Ubaid   +4 more
openaire   +1 more source

Label-Free Photonic Crystal-Based β‑Lactamase Biosensor for β‑Lactam Antibiotic and β‑Lactamase Inhibitor

open access: yes, 2016
A simple, label-free, and visual photonic crystal-based β-lactamase biosensor was developed for β-lactam antibiotic and β-lactamase inhibitor in which the penicillinase (a β-lactamase) was immobilized on the pH-sensitive colloidal crystal hydrogel (CCH ...
Qianshan Chen (3090420)   +5 more
core   +1 more source

The pivotal role of β‐lactone stereochemistry in the development of SARS‐CoV‐2 Mpro inhibitors

open access: yesProtein Science, Volume 35, Issue 7, July 2026.
Abstract From the arrival of the SARS‐CoV‐2 coronavirus in 2019 and its associated COVID‐19 pandemic, worldwide efforts have been focused on developing a drug to treat patients. The SARS‐CoV‐2 main protease (Mpro) is one of the main targets for drug design due to its key role in the virus replication and its distinguished ability to cleave peptides ...
Katarzyna Świderek, Vicent Moliner
wiley   +1 more source

MOESM1 of Genome sequence of Shigella flexneri strain SP1, a diarrheal isolate that encodes an extended-spectrum β-lactamase (ESBL)

open access: yes, 2017
Additional file 1: Table S1. Summary of S. flexneri strain SP1 genome.
Shen, Ping   +10 more
openaire   +1 more source

Toddlers and terriers: a One Health partnership to combat antimicrobial resistance

open access: yes
Journal of Small Animal Practice, EarlyView.
M. Prodanuk, F. Emdin
wiley   +1 more source

Intravesical therapy for recurrent urinary tract infection: a systematic review and meta‐analysis

open access: yesBJU International, Volume 138, Issue 1, Page 33-44, July 2026.
Objective To undertake a systematic review and meta‐analysis to evaluate the efficacy, safety, and clinical applicability of intravesical instillations for preventing recurrent urinary tract infections (rUTIs). Methods PubMed/MEDLINE, Embase, Cochrane CENTRAL, Scopus, and Web of Science were searched from January 2000 to April 2025 for randomised and ...
Matthew Kwon   +3 more
wiley   +1 more source

Additional file 3: Figure S1. of CNN-BLPred: a Convolutional neural network based predictor for β-Lactamases (BL) and their classes

open access: yes, 2017
Validation/Loss curve for Level 1. Figure S2. Validation/Loss curve for Class A. Figure S3. Validation/Loss curve for Class B (Group 3). Figure S4. Validation/Loss curve for Class C (Group 1). Figure S5. Validation/Loss curve for Class D. Figure S6. Validation/Loss curve for Group 2. Figure S7.
White, Clarence   +3 more
openaire   +1 more source

Home - About - Disclaimer - Privacy